India To Export Hcq

India will supply Europe with about 1,000 tonnes of the active pharmaceutical ingredient (API) for common pain reliever paracetamol, a top exports body said, easing export controls on over-the counter medicines used to cope with COVID-19 symptoms.

India has approved 55 countris for exporting anti-malarial drug hydroxychloroquine as grants as well as on commercial basis, official sources said on Thursday.

The government has agreed to sell hydroxychloroquine tablets to Malaysia for use in the treatment of COVID-19 patients, a Malaysian minister told Reuters on Wednesday, with the country partially lifting its bar on exports of the anti-malarial drug.

The Ministry of Health and Family Welfare today said that the government has more than enough stock of Hydroxychloroquine (HCQ) for meeting the current requirement. It said that the Centre has done proper preparation and planning with respect to current and future requirements of HCQ.

One could argue that India doesn't have that many coronavirus patients and therefore, we don't need to keep so much HCQ with us. One could also argue that the idea that HCQ could prevent and cure COVID-19 is more about hope than real scientific evidence. So if Indian companies can make good money from Trump's idiosyncratic optimism about HCQ and a ...

India will supply Europe with about 1,000 tonnes of the active pharmaceutical ingredient (API) for common pain reliever paracetamol, a top exports body said, easing export controls on over-the counter medicines used to cope with COVID-19 symptoms.

India has approved 55 countris for exporting anti-malarial drug hydroxychloroquine as grants as well as on commercial basis, official sources said on Thursday.

The government has agreed to sell hydroxychloroquine tablets to Malaysia for use in the treatment of COVID-19 patients, a Malaysian minister told Reuters on Wednesday, with the country partially lifting its bar on exports of the anti-malarial drug.

The Ministry of Health and Family Welfare today said that the government has more than enough stock of Hydroxychloroquine (HCQ) for meeting the current requirement. It said that the Centre has done proper preparation and planning with respect to current and future requirements of HCQ.

One could argue that India doesn't have that many coronavirus patients and therefore, we don't need to keep so much HCQ with us. One could also argue that the idea that HCQ could prevent and cure COVID-19 is more about hope than real scientific evidence. So if Indian companies can make good money from Trump's idiosyncratic optimism about HCQ and a ...